Search
for
Sort by
Research 661–690 of 1000+
- In response to the letter to the editor by Soha Ghanian et al. re our publication “Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males”
- Clinical Efficacy, Cosmetic Acceptability, and Local Tolerability of a New Formulation of Topical 5% Minoxidil without Propylene glycol: A 6-month, Multicentre, Real-life, Prospective, Assessor-Blinded Study in 196 Subjects with Hair Loss. The andldquo;NOMINALandrdquo; Trial
- Association between psychosocial distress, sexual disorders, self-esteem and quality of life with male androgenetic alopecia: a population-based study with men at age 46
- The “NOMINAL” trial: Clinical efficacy, cosmetic acceptability, and local tolerability of topical 5% minoxidil lotion without propylene glycol: A 6-month, multicentre, real-life, prospective, assessor-blinded study in 196 subjects with hair loss.
- Anaphylactic Shock Due to Intravenous Amiodarone; Delusional Parasitosis Associated with Donepezil; Connubial Androgenetic Alopecia; Ciprofloxacin-Induced Torsade de Pointes; Postvaccination Miller Fisher Syndrome; Life-Threatening Anaphylactoid Shock Caused by Recombinant Tissue Plasminogen Activator; Thiazide-Induced Hyponatremia
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
- Treatment options for polycystic ovary syndrome
- Hidradenitis suppurativa: pathogenesis and management
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
- Symptom Monitoring and Dependent Care During Cancer Treatment in Children
- Ovarian Hypertension: Polycystic Ovary Syndrome
- THERAPY OF ENDOCRINE DISEASE: Treatment of hirsutism in the polycystic ovary syndrome
- Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
- Adolescent Polycystic Ovary Syndrome
- Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome
- Effect of body mass index (BMI) on phenotypic features of polycystic ovary syndrome (PCOS) in Singapore women: a prospective cross-sectional study
- An overview of unwanted female hair
- Managing polycystic ovary syndrome in primary care
- International PCOS guideline clinical research priorities roadmap: a co-designed approach aligned with end-user priorities in a neglected women’s health condition
- Targets to treat androgen excess in polycystic ovary syndrome
- Epidemiological Trends in Alopecia Areata at the Global, Regional, and National Levels
- Integrated Model of Care for Polycystic Ovary Syndrome
- Controversy: is there a role for adjuvants in the management of male pattern hair loss?
- Gender-specific risk factors for androgenetic alopecia in the Korean general population: Associations with medical comorbidities and general health behaviors
- Hirsutism in young women
- How to Evaluate Acne in Reproductive-Age Women: An Epidemiological Study in Chinese Communities
- Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial
- Polycystic Ovary Syndrome (PCOS): From Diagnosis to Treatment
- The Value of Genetic and Non-Genetic Factors in the Emergence and in the Development of Androgenetic Alopecia in Men: Multifactor Analysis